Sergi Vidal-Sicart1, Antonio Seva2,3, Francisco Campos2, Núria Sánchez2, Immaculada Alonso4, Jaume Pahisa4, Xavier Caparrós4, Andrés Perissinotti2, Pilar Paredes2, Fijs W van Leeuwen5. 1. Nuclear Medicine Department, CDI, Hospital Clinic Barcelona, Villarroel 170, 08036, Barcelona, Spain. svidal@clinic.cat. 2. Nuclear Medicine Department, CDI, Hospital Clinic Barcelona, Villarroel 170, 08036, Barcelona, Spain. 3. Nuclear Medicine Department, Hospital Central de la Defensa Gómez Ulla, Madrid, Spain. 4. Gynaecology Department, ICGON, Hospital Clinic Barcelona, Barcelona, Spain. 5. Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands.
Abstract
INTRODUCTION: Guidelines advocate the use of combined detection techniques to achieve optimal results for sentinel node (SN) biopsy. The fluorescent and radioactive (dual-) tracer ICG-99mTc-nanocolloid has been shown to facilitate SN biopsy in several indications. It was reported that an opto-nuclear probe permitted the detection of near-infrared fluorescence and gamma-rays. The aim of the current study was to evaluate this device in a large patient group and to test it in both open and laparoscopic surgery implications. METHODS: Thirty-three patients scheduled for SN biopsy with the dual-tracer were retrospectively analyzed. Pre-operative lymphoscintigraphy was performed in all patients; in 18 patients (55%), a SPECT/CT scan was also performed. Radioactive and fluorescent signatures in the SNs were assessed in vivo and ex vivo using the opto-nuclear probe. RESULTS: One or more SNs were identified in all patients (identification rate 100%). Planar lymphoscintigraphic images revealed 95 hot spots that were considered as SNs. This number increased to 103 SNs when SPECT/CT was used. During surgery, 106 SNs were excised. In vivo, the fluorescence mode of the opto-nuclear probe was able to locate 79 SNs (74.5%). When the gamma-ray detection option of the same probe was used, this number increased to 99 SNs (93.3%). Ex vivo analysis revealed fluorescence in 93.3% of the excised nodes and radioactivity in 95.2%. CONCLUSIONS: This study underlines the feasibility of using the dual-tracer/opto-nuclear probe combination for SN resections. The use of the opto-nuclear technology has been extended to laparoscopic surgery. This study also underlines the fluorescence tracing can complement traditional radio-tracing approaches.
INTRODUCTION: Guidelines advocate the use of combined detection techniques to achieve optimal results for sentinel node (SN) biopsy. The fluorescent and radioactive (dual-) tracer ICG-99mTc-nanocolloid has been shown to facilitate SN biopsy in several indications. It was reported that an opto-nuclear probe permitted the detection of near-infrared fluorescence and gamma-rays. The aim of the current study was to evaluate this device in a large patient group and to test it in both open and laparoscopic surgery implications. METHODS: Thirty-three patients scheduled for SN biopsy with the dual-tracer were retrospectively analyzed. Pre-operative lymphoscintigraphy was performed in all patients; in 18 patients (55%), a SPECT/CT scan was also performed. Radioactive and fluorescent signatures in the SNs were assessed in vivo and ex vivo using the opto-nuclear probe. RESULTS: One or more SNs were identified in all patients (identification rate 100%). Planar lymphoscintigraphic images revealed 95 hot spots that were considered as SNs. This number increased to 103 SNs when SPECT/CT was used. During surgery, 106 SNs were excised. In vivo, the fluorescence mode of the opto-nuclear probe was able to locate 79 SNs (74.5%). When the gamma-ray detection option of the same probe was used, this number increased to 99 SNs (93.3%). Ex vivo analysis revealed fluorescence in 93.3% of the excised nodes and radioactivity in 95.2%. CONCLUSIONS: This study underlines the feasibility of using the dual-tracer/opto-nuclear probe combination for SN resections. The use of the opto-nuclear technology has been extended to laparoscopic surgery. This study also underlines the fluorescence tracing can complement traditional radio-tracing approaches.
Authors: Maaike H M Oonk; François Planchamp; Peter Baldwin; Mariusz Bidzinski; Mats Brännström; Fabio Landoni; Sven Mahner; Umesh Mahantshetty; Mansoor Mirza; Cordula Petersen; Denis Querleu; Sigrid Regauer; Lukas Rob; Roman Rouzier; Elena Ulrikh; Jacobus van der Velden; Ignace Vergote; Linn Woelber; Ate G J van der Zee Journal: Int J Gynecol Cancer Date: 2017-05 Impact factor: 3.437
Authors: Oscar R Brouwer; Nynke S van den Berg; Hanna M Mathéron; Henk G van der Poel; Bas W van Rhijn; Axel Bex; Harm van Tinteren; Renato A Valdés Olmos; Fijs W B van Leeuwen; Simon Horenblas Journal: Eur Urol Date: 2013-11-26 Impact factor: 20.096
Authors: Henk G van der Poel; Tessa Buckle; Oscar R Brouwer; Renato A Valdés Olmos; Fijs W B van Leeuwen Journal: Eur Urol Date: 2011-04-01 Impact factor: 20.096
Authors: Robert W Holloway; Nadeem R Abu-Rustum; Floor J Backes; John F Boggess; Walter H Gotlieb; W Jeffrey Lowery; Emma C Rossi; Edward J Tanner; Rebecca J Wolsky Journal: Gynecol Oncol Date: 2017-05-28 Impact factor: 5.482
Authors: M-A Poumellec; M Dejode; A Figl; J Darcourt; J Haudebourg; Y Sabah; A Voury; A Martaens; E Barranger Journal: Gynecol Obstet Fertil Date: 2016-03-17
Authors: Francesco Giammarile; Naomi Alazraki; John N Aarsvold; Riccardo A Audisio; Edwin Glass; Sandra F Grant; Jolanta Kunikowska; Marjut Leidenius; Valeria M Moncayo; Roger F Uren; Wim J G Oyen; Renato A Valdés Olmos; Sergi Vidal Sicart Journal: Eur J Nucl Med Mol Imaging Date: 2013-10-02 Impact factor: 9.236
Authors: Ryan M Davis; Jos L Campbell; Sean Burkitt; Zhen Qiu; Soyoung Kang; Mana Mehraein; Dominie Miyasato; Helen Salinas; Jonathan T C Liu; Cristina Zavaleta Journal: Nanomaterials (Basel) Date: 2018-11-20 Impact factor: 5.076
Authors: Imke Boekestijn; Matthias N van Oosterom; Paolo Dell'Oglio; Floris H P van Velden; Martin Pool; Tobias Maurer; Daphne D D Rietbergen; Tessa Buckle; Fijs W B van Leeuwen Journal: Cancer Imaging Date: 2022-09-06 Impact factor: 5.605